NCT07087158 2025-07-28A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell CarcinomaImbioray (Hangzhou) Biomedicine Co., Ltd.Phase 2 Not yet recruiting30 enrolled